logo

For the Inventor, By the Inventor

Kanagawa, Japan

Tomoaki Miura

This inventor holds 12 USPTO granted patents and 2 EPO patents. Top assignees: Meiji Seika Kabushiki Kaisha, Meiji Seika Kaisha, Ltd., Taisho Pharmaceutical Co., Ltd.. Active years: 1997-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomoaki Miura. Retrieved from https://idiyas.com/inventor/tomoaki-miura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 50.0

 

Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 44(Granted Patents)


Location History:

  • Kanagawa-ken, JP (1997 - 1999)
  • Yokohama, JP (2002 - 2003)
  • Kanagawa, JP (2008 - 2015)

Company Filing History:

goldMedal5 out of 32 
 
Meiji Seika Kabushiki Kaisha
 patents
silverMedal4 out of 382 
 
Meiji Seika Kaisha, Ltd.
 patents
bronzeMedal4 out of 314 
 
Taisho Pharmaceutical Co., Ltd.
 patents
4. 3 out of 107 
 
Meiji Seika Pharma Co., Ltd.
 patents
where one patent can have more than one assignee

Years Active: 1997-2015

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 9139609 - C-4″ position substituted macrolide derivative (2015-09-22),
2. 8299035 - 10a-azalide compound having 4-membered ring structure (2012-10-30),
3. 8293715 - 10a-Azalide compound crosslinked at 10a- and 12-positions (2012-10-23),
4. 8097708 - 10a-Azalide compound (2012-01-17),
5. 7365174 - Azalide and azalactam derivatives and method for producing the same (2008-04-29),
6. 6660718 - 3-modified leucomycin derivatives (2003-12-09),
7. 6472397 - Nitrogen-containing heterocyclic compounds having antiplatelet aggregation effect and medicinal use thereof (2002-10-29),
8. 5958981 - .gamma.-diketone compounds with inhibitory activity against platelet (1999-09-28),
9. 5814636 - Compounds with platelet aggregation inhibitor activity (1998-09-29),
10. 5760053 - .gamma.-Diketone compounds with inhibitory activity against platelet (1998-06-02),
11. 5698692 - Compound with platelet aggregation inhibitor activity (1997-12-16),
12. 5594004 - Compound with platelet aggregation inhibitor activity (1997-01-14),

Title: The Innovative Contributions of Tomoaki Miura

Introduction

Tomoaki Miura is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing macrolide compounds. With a total of 12 patents to his name, Miura's work has been instrumental in addressing antibiotic resistance.

Latest Patents

Among his latest patents is the "C-4″ position substituted macrolide derivative." This macrolide compound is effective against erythromycin-resistant bacteria, including resistant pneumococci, streptococci, and mycoplasmas. Another notable patent is the "10a-azalide compound having a 4-membered ring structure." This compound is crosslinked at the 10- and 12-positions and is also effective against erythromycin-resistant bacteria.

Career Highlights

Miura has worked with several reputable companies in the pharmaceutical industry, including Meiji Seika Kabushiki Kaisha and Taisho Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to develop innovative solutions to pressing health issues.

Collaborations

Throughout his career, Miura has collaborated with notable colleagues, including Eiki Shitara and Kiyoaki Katano. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Tomoaki Miura's contributions to pharmaceutical innovation are noteworthy, particularly in the fight against antibiotic resistance. His patents reflect a commitment to improving healthcare through scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…